POMALIDOMIDE Pharmacologic Class Indexing
- Class set ID
- 06302252-c8c2-4d73-9f76-6c8afcbf6c9c
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES . POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 2013 | Apotex Corp. | Apotex Inc. | 20260311 | 2 |
| These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 2013 | Breckenridge Pharmaceutical, Inc. | Natco Pharma Ltd. | 20260304 | 10 |
| These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 2013 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20260304 | 2 |
| These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES . POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 2013 | Teva Pharmaceuticals, Inc. | 20260302 | 1 |
| These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 2013 | Aurobindo Pharma Limited | Apicore Pharmaceuticals Private Limited | EUGIA Pharma Specialities Limited | 20260130 | 1 |
| These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 2013 | Natco Pharma Limited | 20251118 | 1 |
| These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST ® (pomalidomide) capsules, for oral use Initial U.S. Approval: 2013 | Celgene Corporation | 20250226 | 26 |